Sarepta???s Exondys 51 Saga Continues as More Details About FDA???s Criticism Uncovered Post author:Sam Post published:August 21, 2017 Post category:BioPharma August 22, 2017By Mark Terry… Source: BioSpace You Might Also Like Rumors Swirl Again Over AstraZeneca PLC and This $4.4 Billion San Diego Biotech September 7, 2017 Array BioPharma And Bristol-Myers Squibb Announce Strategic Collaboration May 29, 2017 Biogen Halts Plans to Develop Tysabri for Stroke After Phase IIb Trial Flop February 6, 2018
